Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page
- Check2 days agoChange DetectedAdded Fundacao Pio XII - Hospital de Barretos (Barretos, Brazil) with Josiane Mourao Dias at site 007-457 and phone +55 1733 216600; added Universitatsklinikum Augsburg with Bjorn Hackanson at site 007-2222 and phone +498214002729; added Local Institution 007-743-Ph3; updated Primary Completion date to 2028-10-31 and Study Completion date to 2029-10-31 with a Completed status. Removed prior site records and contacts for Xinjiang Medical University Cancer Hospital - Urumqi, Site 007-457, Site 007-2222, and associated not-yet-recruiting/contacts.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page's revision tag was bumped from v3.6.2 to v3.6.3, indicating a small update to the page's content or metadata.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page revision has been updated from v3.6.0 to v3.6.2, indicating a newer build of the page; this is an internal update with no explicit user-facing content changes.SummaryDifference0.0%

- Check26 days agoChange DetectedThe study record has been expanded with numerous new global locations and investigators, increasing the reach to 770 locations and updating site details and contacts. At the same time, several existing site entries and contacts were removed or changed, reflecting a cleanup or reorganization of local institutions.SummaryDifference0.3%

- Check50 days agoChange DetectedNew recruitment locations and site contacts have been added (e.g., Teresa Garcia Manrique in Seville; Saitama Medical University International Medical Center; Gleneagles Penang), expanding the study's recruitment footprint. The total number of locations is updated to 767.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page revision tag was updated to Revision: v3.5.4, replacing the previous v3.5.3. This indicates the page version was updated, likely including minor edits or fixes without changing the study details.SummaryDifference0.0%

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.